Corteva/$CTVA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Corteva

Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.

Ticker

$CTVA
Sector

Primary listing

NYSE

Industry

Chemicals

Employees

22,000

ISIN

US22052L1044

Corteva Metrics

BasicAdvanced
$51B
45.13
$1.65
0.72
$0.68
0.91%

What the Analysts think about Corteva

Analyst ratings (Buy, Hold, Sell) for Corteva stock.

Bulls say / Bears say

Corteva's first-quarter 2025 adjusted operating profit exceeded expectations at $1.13 per share, driven by a 3% increase in seed prices, particularly in North America. (reuters.com)
The company introduced Forcivo™ fungicide in June 2025, offering triple-action foliar disease control for crops like corn and soybeans, potentially enhancing its product portfolio and market share. (corteva.us)
Corteva's strategic acquisitions of Stoller Group and Symborg in 2023 have bolstered its position in the biologicals market, aligning with the growing demand for sustainable agricultural solutions. (prnewswire.com)
In the third quarter of 2024, Corteva reported a larger-than-expected loss, with net sales declining 10% to $2.33 billion, leading to a downward revision of its full-year sales forecast. (reuters.com)
The strengthening U.S. dollar poses a significant headwind for Corteva, as it reduces the value of sales generated in foreign currencies, particularly impacting regions like Latin America. (monexa.ai)
Corteva's 2025 earnings forecast of $2.70 to $2.95 per share fell short of analysts' expectations of $3.13, leading to a share price decline of over 4% after the announcement. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 28 Jun 2025.

Corteva Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Corteva Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CTVA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs